Many U.S. physicians feel that health care digitization has created serious headaches with limited benefits for patients. Will machine learning soon change their minds? Partners HealthCare, a health care system that oversees two world-class Boston hospitals, certainly thinks so.
BenevolentAI is a UK-based biotechnology company betting on machine learning and artificial intelligence as their competitive advantage at all stages of the drug development process. Will this bet pay off or will BenevolentAI fail to create meaningful innovation in the biotech space?
Machine learning has been touted as a potential cure-all for high drug prices. A number of leading biopharmaceutical companies like Roche have made some large bets in using artificial intelligence tools to improve drug development, but it remains to be seen if machine learning is living up to its hype.
Machine-learning driven advancements in healthcare have promised much but left us waiting. Will the UK National Health Service's latest effort fare any better?
Can Verb Surgical use advanced robotics and machine learning to deliver high quality surgical care to the 5 billion  people around the world who desparately need it?
The digitalization of healthcare has added greater complexity and costs, and Memorial Sloan-Kettering Cancer Center believes artificial intelligence may be the solution.
How the "Internet of Things" is impacting the pharma industry
Startup PillPack shows us how drug-dispensing robots and textable pharmacists can provide peace of mind at no extra cost to customers.
Ever gone to the doctor and been unable to look your physician in the eye? Was it because you were embarrassed to say something or because he or she had his or her head down trying to type your entire response into the new Electronic Health Record? EHRs have ushered in a new era of modern medicine, but is it all good?
Edible microchips enable real-time tracking of patient health.